Herein, inclusion complexation of host β-CD with guests,
viz. nicotinamide and pyridoxine (two active forms of vitamins), in
both aqueous medium and solid state has been explored by means of
various spectroscopic and physicochemical procedures. In vivo toxicity
and in vitro anti-inflammatory properties in experimental rat models
through membrane stabilization and protein denaturation test are studied
here. These imperative complexes, when orally consumed, showed no
toxic effect in experimental rats equal to the dose (400 mg/kg) of
body weight when fed up to 28 days. Binding constants for the inclusion
complexes have been designed by the Stern–Volmer approximation
method and found to be higher for pyridoxine, elucidated on account
of their molecular structural representation. Additionally, molecular
docking aided to enlighten the most possible mode of interactions
among guests and β-CD. Both of the encapsulated systems could
potentially find applications in vitamin B3 and vitamin
B6 formulation for the purpose of enhancing stability,
absorption, and controlled delivery of these imperative vitamins.
The use of β-CD as a drug delivery vehicle with vitamin B substituents
into eukaryotic cells is well documented and thus increases the bioavailability
of diverse therapeutics.